Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.50
Bid: 1.45
Ask: 1.55
Change: 0.025 (1.69%)
Spread: 0.10 (6.897%)
Open: 1.475
High: 1.525
Low: 1.475
Prev. Close: 1.475
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages

Thu, 09th Feb 2023 11:19

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Genedrive PLC, up 34% at 33.47 pence, 12-month range 8p-42p. The molecular diagnostics company says the UK's National Institute for Health & Care Excellence has preliminarily recommended its antiobiotic-induced hearing loss test for use in the National Health Service. NICE's final guidance will follow a public consultation period, which will close on February 21. "We encourage relevant stakeholders to participate during the public consultation period to support our pioneering work, and look forward to receiving the final NICE report," says CEO David Budd.

----------

Shield Therapeutics PLC, up 12% at 6.9p, 12-month range 5.5p-36p. The commercial stage pharmaceutical company updates on its annual performance, and now expects revenue of GBP8.5 million, multiplied year-on-year from GBP1.5 million. Says the period was a "landmark" year for Accrufer, its novel oral iron therapy. CEO Greg Madison notes its sales collobration with Viatris is "off to a great start".

----------

AIM - LOSERS

----------

Zytronic PLC, down 11% at 134p, 12-month range 110p-192.49p. The touch sensors manufacturer says the performance in the first four months of its financial year has been hit by ongoing global supply chain issues, leading to a shortage of some electronic components. Consequently, it has needed to buy some of these at a higher price on the "grey market", or cannibalise its existing stock. Also notes potential rising costs from proposed increases to national minimum wage and nation living wage in the UK, as well as wage negotiations with its employee representatives. It now expects revenue to be more weighted towards the second half than in the previous year.

----------

Beowulf Mining PLC, down 8.0% at 3p, 12-month range 2.38p-22.2p. The mining company launches a retail offer of up to 104.0 million new shares at 2.06p, which is around a 31% discount to its closing price on Wednesday. It plans to raise around GBP2.1 million in gross proceeds, which it will put towards its workstreams. Also conducts a preferential rights issue of up to 316.7 million Swedish depositary receipts to raise around GBP6.8 million.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 Apr 2018 12:56

Genedrive To Unveil Hepatitis C ID Kit In Singapore Exhibition

LONDON (Alliance News) - Molecular diagnostics firm Genedrive PLC said Tuesday it is to premiere its hepatitis C ID kit in the Asia Pacific at an in will

Read more
20 Mar 2018 13:59

Genedrive Confident For Future As Interim Loss Narrows On Lower Costs

LONDON (Alliance News) - Genedrive PLC said on Tuesday that its pretax loss narrowed in the first half of the financial year as financing costs reduced for six months to the a

Read more
13 Mar 2018 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 14 March PrudentialFull Year ResultsDignityFull Year MacdonaldHalf 15

Read more
27 Jan 2017 09:42

Genedrive's revenues rise despite difficulties in India

(ShareCast News) - Genedrive, an AIM listed near patient molecular diagnostics diagnostics company, has progressed well in the second half despite difficulties faced with its Tuberculosis (TB) assay in India. Group revenues "significantly" rose to £2.8m for six months ended 31 December 2016, up f

Read more
16 Jan 2017 16:11

Genedrive supplies field test units to US DoD

(ShareCast News) - Manchester-based diagnostics company genedrive announced on Monday that it has supplied Genedrive units and assays to the United States Department of Defense for field trials, as part its $7.8m development programme for a handheld device to allow for the detection of biohazards su

Read more
17 Nov 2016 09:53

Genedrive Human Genotyping Test Gets EU Certification

Read more
11 Oct 2016 14:05

Genedrive's revenue rises while it re-focuses company

(ShareCast News) - AIM-listed molecular diagnostics company Genedrive's revenue grew as it re-focused to concentrate on its Genedrive platform, launched a new test in India and changed its name. For the year ended 30 June, the company, formerly Epistem, reported 12% growth in turnover to £5.1m, comp

Read more
11 Oct 2016 13:11

CORRECT: Genedrive Loss Widens As Product Sales Slow To Materialise

Read more
21 Sep 2016 08:43

Genedrive appoints Matthew Fowler CFO

(ShareCast News) - AIM-listed molecular diagnostic company Genedrive appointed Matthew Fowler as chief financial officer and a member of the board. He will start at a date to be confirmed shortly and will replace John Rylands who has been with company since 2002. Fowler joins Gendrive from Scapa Gr

Read more
2 Aug 2016 09:19

Genedrive Sees Strong Revenue Increase But Wider Annual Loss

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.